Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukushima, S.
Right arrow Articles by Yamamoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukushima, S.
Right arrow Articles by Yamamoto, S.
(Journal of Nutrition. 2001;131:1049S-1053S.)
© 2001 The American Society for Nutritional Sciences


Supplement: Recent Advances on the Nutritional Effects Associated with the Use of Garlic as a Supplement

Suppression of Chemical Carcinogenesis by Water-Soluble Organosulfur Compounds1

Shoji Fukushima2, Nobuyasu Takada, Takaaki Hori, Wei Min, Hideki Wanibuchi and Shinji Yamamoto

Department of Pathology, Osaka City University Medical School, Osaka 545-8585, Japan

2To whom correspondence should be addressed. E-mail: fukuchan{at}med.osaka-cu.ac.jp.

ABSTRACT

The chemopreventive effects of five water-soluble organosulfur compounds, S-methylcysteine (SMC) and four analogs, were examined on the promotion stage of diethylnitrosamine hepatocarcinogenesis in male F344 rats, using the medium-term bioassay (Ito test), which is based on the two-step model of hepatocarcinogenesis. In addition, we investigated the modifying effects of SMC and cysteine on the initiation stage of rat hepatocarcinogenesis. Carcinogenic potential was scored by comparing the numbers and areas of a putative neoplastic lesion, glutathione S-transferase placental form (GST-P)–positive hepatocellular foci. SMC and cysteine significantly decreased the number and area of GST-P–positive foci when given in the promotion stage of the Ito test. When given during the initiation stage, these two organosulfur compounds also significantly inhibited focus formation. Liver ornithine decarboxylase activity after two thirds partial hepatectomy and the proportion of hepatocytes positive for proliferating cell nuclear antigen significantly decreased the number of aberrant crypt foci in the colon in a multiorgan carcinogenesis bioassay of rats. These results support SMC and cysteine as chemopreventive agents for hepatocarcinogenesis and colon carcinogenesis. Their intake may be of importance for cancer.


KEY WORDS: • chemoprevention • cacinogenesis • water-soluble organosulfur compounds • S-methylcysteine • cysteine • garlic

Environmental compounds are likely involved in the development of many human cancers. Their elimination would be expected to help with the prevention of cancer. However, this is not a practical proposition; therefore, it is important to discover naturally occurring or synthetic compounds that might suppress or prevent the process of carcinogenesis.

It is well-known that both oil-soluble and water-soluble organosulfur compounds (OSC)3 are contained in garlic and onions. Some of these, particularly oil-soluble OSC, have been shown to be chemopreventive in the initiation stage of carcinogenesis. For example, diallyl sulfide (DAS) inhibits the development of colon carcinomas, esophageal carcinomas, pulmonary adenomas and forestomach tumors in rodents when administered before carcinogen exposure (Sparnins et al. 1988Citation , Wargovich 1987Citation , Wargovich et al. 1998, Wattenberg et al. 1989Citation ). In addition, DAS has been found to inhibit hepatocarcinogenesis when administered after the initiating procedure (Wattenberg et al. 1989Citation ). However, there is a lack of data on the chemopreventive effect when administered during the promotion stage of carcinogenesis. Administration of oil-soluble OSC after initiation with diethylnitrosamine (DEN), either enhanced or inhibited glutathione S-transferase placental form (GST-P)-positive foci in rat liver (Takada et al. 1994a and 1994bCitation Citation ).

S-Methylcysteine (SMC), a water-soluble OSC, exists in various plants, including Allium sativum (Suzuki et al. 1961Citation ), Phaseolus vulgaris (Thompson et al. 1956Citation ), and Cruciferae (Synge and Wood 1956Citation ). Although its biological characteristics have not received much attention, Sumiyoshi and Wargovich (1990)Citation reported that S-allylcysteine (SAC), an analog of SMC, can prevent 1,2-dimethylhydrazine (DMH)-induced colon cancer in mice.

In this study, the modifying potentials of five water-soluble OSC, SMC and four analogs were examined in the rat liver medium-term bioassay system of Ito et al. (1988)Citation and the multiorgan carcinogenesis bioassay based on the two-stage carcinogenesis model (Takahashi et al. 1992bCitation ). The four analogs of SMC examined in this study were cysteine, SAC, S-propylcysteine (SPC), and S-ethylcysteine (SEC). In another experiment, the modifying effects of SMC and cysteine given during the initiation stage of rat hepatocarcinogenesis were investigated as previously described (Tsuda et al. 1994Citation ).

Cancer prevention in hepatocarcinogenesis

Ito et al. (1988 and 1989)Citation Citation developed a medium-term bioassay system to detect liver carcinogens and promoters; it is of relatively short duration but results in sufficient lesions to allow statistical comparisons. A series of experiments were performed to optimize the different components of the model as well as a liver medium-term bioassay for carcinogens (Ito test). A duration of 8 wk was established. Importantly, this rat liver medium-term bioassay can be applied to detect not only the carcinogenic potential of chemicals, but also their postinitiation modifying effects. The rat liver has the particular advantage of easy detection of preneoplastic enzyme-altered foci, widely accepted as early indicators of cancer (Bannasch 1986Citation , Farber and Cameron 1980Citation ). GST-P-positive foci in the rat liver correlate with hepatocellular carcinomas; thus, they have been routinely employed as an end-point marker in this assay system (Ito et al. 1988 and 1989Citation Citation ).

Experiment 1 investigated the modifying effects of each OSC on the second stage of hepatocarcinogenesis using the Ito test (Takada et al. 1997Citation ). The experimental design is shown in Figure 1Citation . The rats in groups 1–6 (n = 10 rats/group) were given a single intraperitoneal injection of DEN (200 mg/kg body) dissolved in saline to initiate hepatocarcinogenesis. After 2 wk, they received SAC (groups 1 and 7), SPC (groups 2 and 8), SEC (groups 3 and 9), SMC (groups 4 and 10), or cysteine (groups 5 and 11), each at a dose of 100 mg/kg body dissolved in saline (4 or 8 mL/kg), and administered by gastric gavage 5 times/wk for 6 wk. Rats were subjected to two thirds partial hepatectomy (PH) at wk 3 to maximize any interaction between proliferation and the effects of the compounds tested. Control rats (group 6) were given DEN and PH, followed by saline without administration of any OSC compounds. Groups 7–11 (n = 5/group) received saline instead of DEN solution, but were subjected to administration of test compounds and PH. Rats in each group were killed for examination at the end of wk 8. The livers were examined immunohistochemically for GST-P positive-focus formation. No significant intergroup variation was found in the final body weight of rats treated or untreated with OSC. Figure 2Citation summarizes the data for numbers and areas of GST-P positive foci per unit area of liver section after DEN initiation in Experiment 1. Values for numbers and areas in groups 1–3 treated with test chemicals tended to be decreased compared with those in controls. Values for both parameters in the groups that were given SMC (group 4) or cysteine (group 5) were significantly decreased. In particular, group 4 values were less than half of those in controls. Livers from groups not given DEN did not have GST-P-positive foci and revealed normal histology.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 1. Liver medium-term bioassay protocol. {diamondsuit}, DEN, 200 mg/kg body (intraperitoneal); {diamond}, saline, 5 mL/kg body (intraperitoneal); {downarrow}, two thirds partial hepatectomy; S, killing; , test chemicals (intragastric) 5 times/wk; , saline, 1 mL/kg body (intragastric).

 


View larger version (37K):
[in this window]
[in a new window]
 
Figure 2. Numbers and areas of glutathione S-transferase placental form (GST-P)-positive foci in the livers of rats initiated with diethylnitrosamine (DEN) followed by treatment with various water-soluble organosulfur compounds (OSC). Values are means ± SD; *significantly different from group 6 at P < 0.05; **significantly different from group 6 at P < 0.01. Abbreviations: SAC, S-allyl cysteine; SPC, S-propylcysteine; SEC, S-ethylcysteine; SMC, S-nethylcysteine.

 
Experiment 2 examined the modifying effects of SMC and cysteine on the initiation stage of hepatocarcinogenesis,. The experimental design is shown in Figure 3Citation . Rats (n = 42) were divided into five groups; groups 1–3 were given a single intraperitoneal injection of DEN (20 mg/kg body) dissolved in saline, whereas groups 4 and 5 received saline instead of the DEN solution. SMC (groups 1 and 4) or cysteine (groups 2 and 5) were administered at 100 mg/kg body dissolved in saline, once a day from 5 d before DEN or saline injection to 1 d after. Rats in group 3 were given saline intragastrically instead of OSC. All rats were fed 0.01% 2-acetylaminofluorene (2-AAF) in the diet from wk 2 to 4 and subjected to PH at wk 3. Numbers and areas of GST-P positive foci in Experiment 2 are shown in Table 1Citation . Values for both parameters in groups 1 and 2 were decreased compared with those in group 3. GST-P-positive foci occurred sporadically in groups 4 and 5, without DEN and with 2-AAF.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Protocol for examination of modifying effects on the initiation stage. {diamondsuit}, diethylnitrosamine (DEN), 20 mg/kg body (intraperitoneal); {diamond}, saline, 5 mL/kg body (intraperitoneal); {downarrow}, two thirds partial hepatectomy (PH); S, killing; {blacktriangledown}, test chemicals (intragastric); {triangledown}, saline, 1 mL/kg body (intragastric); 2-AAF, 2-acetylaminofluorene.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Numbers and areas of GST-P-positive foci in the livers of rats in Experiment 2, with or without DEN initiation after treatment with SMC or cysteine12

 
The activities of ornithine decarboxylase (ODC) and spermidine/spermine N1-acetyltransferase (SAT), rate-limiting enzymes of polyamine metabolism that are reported to be increased by promoters of chemical carcinogenesis (Matsui-Yuasa et al. 1992Citation , O’Brien et al. 1975Citation ), were measured in SMC- and cysteine-treated liver tissues after PH. The expression of proliferating cell nuclear antigen (PCNA) was examined immunohistochemically in SMC- and cysteine-treated livers. Because cell proliferation is generally low in the normal liver of adult rats, PH was used for the next two experiments.

In Experiment 3, the relation between cell proliferation and inhibitory effects of SMC and cysteine on liver ODC and SAT activities in liver was examined. Rats (n = 5) were fed SMC or cysteine (100 mg/kg body, intragastrically) at 0, 24 and 48 h before PH. The control group (n = 5) received saline alone. All rats were killed 4 h after PH, and ODC and SAT activities were assessed. The results for ODC and SAT activities in rat liver tissues after PH in Experiment 3 are summarized in Table 2Citation . ODC activities 4 h after PH were significantly decreased in SMC- or cysteine-treated liver tissue compared with controls. Mean SAT activities were also lower in SMC- and cysteine-treated rats, but were not significantly different from controls.


View this table:
[in this window]
[in a new window]
 
Table 2. ODC and SAT activities in rat liver at 4 h after PH12

 
Experiment 4 examined sequential changes in PCNA-positive cells due to SMC and cysteine treatment. Rats (n = 6) were fed SMC or cysteine (100 mg/kg body, intragastrically) at 0, 24 and 48 h before PH; the control group received saline alone before PH. The liver tissue removed at PH was used as the zero time control. Rats in the two groups were killed at 4 and 24 h, respectively, after the final intragastric administration. PCNA-positive cells were stained immunohistochemically and counted. PCNA-positive cells at 4 h were significantly decreased in SMC- or cysteine-treated liver compared with the control group (Table 3Citation ). Moreover, even after 24 h, some reduction was still apparent.


View this table:
[in this window]
[in a new window]
 
Table 3. PCNA-positive cells in rat liver at 0, 4 and 24 h after PH12

 
In Experiment 5, the influence of SMC on the expression of c-fos, c-jun and c-myc protooncogenes was assessed. All rats underwent PH. SMC was administered intragastrically at 100 mg/kg body at 0, 24 and 48 h before PH in group 1 (n = 5). Group 2 (n = 5), received saline in the same time periods. The liver tissue removed at PH was used as the control, and single rats in each group were killed at 2, 4, 8, 12 and 24 h, respectively, after the final intragastric administration. Data from image analyzer quantification are given in Figure 4Citation . Maximum expression of c-fos, c-jun, c-myc in the rat liver without SMC treatment was observed at 2, 8 and 8 h, respectively, after PH. Northern blot analysis revealed that only the expression of c-jun in the rat liver was obviously altered by SMC treatment. SMC was associated with a down-regulation of c-jun during the first 8 h after PH; however, there was an increase at the 12-h time point.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. Quantification of sequential changes in early response genes; (a) c-fos, (b) c-jun, (c) c-myc. (•, S-methylcysteine (SMC) treatment; {circ}, no treatment).

 
Nitrites and amines are known to react under the acidic condition of the stomach to form carcinogenic N-nitrosamines. As precursors, NaNO2 and morpholine are high risk factors for human carcinogenesis. To examine the inhibitory effect of SMC on hepatocarcinogenesis, rats were given 0.15% NaNO2 in drinking water and 0.5% morpholine in diet with or without SMC at a dose of 100 mg/kg body by intragastric intubation, 5 times/wk for 6 wk in the Ito test (Ito et al. 1988Citation ). The area of GST-P positive foci in the group treated with SMC (0.32 ± 0.19 mm2/cm2) was significantly less than in those not receiving SMC (0.60 ± 0.39 mm2/cm2). The number of GST-P positive foci in SMC-treated rats was lower than in controls, although not significantly different. There were no alterations in the amount and concentration of N-nitrosomorpholine in the stomach between the two groups. These data indicated that SMC can suppress hepatocarcinogenesis caused by nitrites and amines possibly by altering their metabolism.

Cancer prevention in carcinogenesis of organs other than the liver

An alternative assay for detecting carcinogenicity and modifying (promoting or inhibiting) activity is the multiorgan carcinogenesis bioassay (Ito et al. 1991Citation , Otoshi et al. 1995Citation , Takahashi et al. 1992a and 1992bCitation Citation ). It has the advantage of being a short-term assay of whole-body carcinogenic or modifying potential. Using the best multiorgan carcinogenesis assay among several systems investigated to date, we assessed the influence of SMC and cysteine on the postinitiation stage (Fig. 5Citation ).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Multiorgan carcinogenesis bioassay protocol. {downarrow}, DEN, 100 mg/kg body (intraperitoneal); {triangledown}, N-methyl-N-nitrosourea (MNU), 20 mg/kg body (intraperitoneal); , N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), 0.05% in the drinking water; {blacktriangledown}, 1,2-dimethylhydrazine (DMH), 40 mg/kg body (subcutaneous); , dihydroxy-di-propylnitrosamine (DHPN), 0.1% in the drinking water; , test compounds.

 
In the present case, F344 rats were divided into three groups. Groups 1 and 2 were treated sequentially with DEN (100 mg/kg body, single intraperitoneal dose) at the commencement, N-methyl-N-nitrosourea (MNU, 20 mg/kg body, intraperitoneally) on d 2, 5, 8 and 11 and DMH (40 mg/kg body, subcutaneously) on d 14, 17, 20 and 23. Rats were simultaneously given N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN, 0.05% in the drinking water) during wk 1 and 2 and dihydroxy-di-propylnitrosamine; (DHPN, 0.1% in the drinking water) during wk 3 and 4. After this combination treatment with DEN, MNU, BBN, DMH and DHPN (DMBDD), group 1 rats were administered SMC or cysteine, dissolved in corn oil, at doses of 100 mg/kg body, 5 times/wk by intragastric intubation for 31 wk. Group 2 rats were given a basal diet and tap water after the DMBDD treatment and served as the control. Group 3 received the vehicles without carcinogens in the first stage, followed by test chemicals. SMC and cysteine significantly decreased the numbers of aberrant crypt foci in the colon (Tudek et al. 1989Citation ). However, no equivalent depression in the induction of colon tumors was observed. The results of quantitative evaluation of GST-P-positive foci in the liver revealed that the numbers and areas were significantly lower in the group treated with SMC or cysteine than in controls. There were no differences in other organs among SMC, cysteine and control rats.

DISCUSSION

Our results indicate that OSC such as SMC and cysteine exert chemopreventive effects against chemical carcinogenesis in rats. SMC and cysteine at the level of 100 mg/kg body was toxic. SMC is found at a concentration of ~40 µg/g of fresh garlic (personal communication from Wakunaga Pharmaceutical Co., Ltd.). Examination of low dose-response relationships for inhibitory effects of SMC and cysteine are warranted to evaluate their usefulness as chemopreventive agents at lower intakes. Moreover, it is very important to determine whether SMC and cysteine promote carcinogenesis in other organs.

The fact that SMC and cysteine prevented elevation of ODC and SAT in the liver suggests a possible mechanism accounting for the prevention of hepatocarcinogenesis by such OSC. These data suggest that a down-regulation of polyamine metabolism may be involved.

Expression of early response genes may be very important for tumor promotion. Expression of c-jun mRNA was down-regulated for the first 8 h after the final intragastric administration of SMC, whereas levels of c-fos mRNA transcripts were not changed compared with controls. These data suggest that formation of Fos-Jun heterodimers, which are strongly linked to AP-1 sites, is decreased in rat liver treated with SMC and that a suppression in preneoplastic lesions in rat liver might be related.

In conclusion, our results indicate that SMC and cysteine exert chemopreventive effects on chemical carcinogenesis of rats. Additional studies are warranted to define the minimum quantities necessary to produce this effect and the mechanism responsible.

ACKNOWLEDGMENTS

We would like to express our gratitude to Shuzo Otani and Yoshihisa Yano at the Department of Biochemistry, Osaka City University Medical School for helping with this study and to Wakunaga Pharmaceutical, Osaka for providing the chemicals.

FOOTNOTES

1 Presented at the conference "Recent Advances on the Nutritional Benefits Accompanying the Use of Garlic as a Supplement" held November 15–17, 1998 in Newport Beach, CA. The conference was supported by educational grants from Pennsylvania State University, Wakunaga of America, Ltd. and the National Cancer Institute. The proceedings of this conference are published as a supplement to The Journal of Nutrition. Guest editors: John Milner, The Pennsylvania State University, University Park, PA and Richard Rivlin, Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Center, New York, NY. Back

3 Abbreviations used: 2-AAF, 2-acetylaminofluorene; BBN, N-butyl-N-(4-hydroxybutyl)nitrosamine; DAS, diallyl sulfide; DEN, diethylnitrosamine; DHPN, dihydroxy-di-propylnitrosamine; DMBDD, combination treatment with DEN, MNU, BBN, DMH and DHPN; DMH, 1,2-dimethylhydrazine; GST-P, glutathione S-transferase placental form; MNU, N-methyl-N-nitrosourea; ODC, ornithine decarboxylase; OSC, organosulfur compounds; PCNA, proliferating cell nuclear antigen; PH, partial hepatectomy; SAC, S-allylcysteine; SAT, spermidine/spermine N'-acetyltransferase; SEC, S-ethylcysteine; SMC, S-methylcysteine; SPC, S-propylcysteine. Back

REFERENCES

1. Bannasch P. Commentary. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic neoplasia. Carcinogenesis 1986;7:689-695[Free Full Text]

2. Farber E., Cameron R. The sequential analysis of cancer development. Adv. Cancer Res. 1980;31:125-226[Medline]

3. Ito N., Imaida K., Hasegawa R., Tsuda H. Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis. CRC Crit. Rev. Toxicol. 1989;19:385-415

4. Ito N., Shirai T., Fukushima S. Medium-term bioassay for carcinogens using multiorgan models. Ito N. Sugano H. Karger S. eds. Progress in Experimental Tumor Research 1991;33:41-57 Karger Basel, Switzerland. [Medline]

5. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., Asamoto M. Enhancing effects of various hepatocarcinogenes on induction of preneoplastic glutathione S-transferase placental form positive foci in rat—an approach for a new medium-term bioassay system. Carcinogenesis 1988;9:387-394[Abstract/Free Full Text]

6. Matsui-Yuasa I., Otani S., Yano Y., Takada N., Shibata M., Fukushima S. Spermidine/spermine N'-acetyltransferase, a new biochemical marker for epithelial proliferation in rat bladder. Jpn. J. Cancer Res. 1992;83:1037-1040[Medline]

7. O’Brien T. G., Simsiman R. C., Boutwell R. K. Induction of polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res 1975;35:2426-2433[Abstract/Free Full Text]

8. Otoshi T., Iwata H., Kitano M., Nishizawa Y., Morii H., Yano Y., Otani S., Fukushima S. Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat clone carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1{alpha},25-dihydroxyvitamin D3. Carcinogenesis 1995;16:2091-2097[Abstract/Free Full Text]

9. Sparnins V. L., Barany G., Wattenberg L. W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 1988;9:131-134[Abstract/Free Full Text]

10. Sumiyoshi H., Wargovich M. J. Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 1990;50:5084-5087[Abstract/Free Full Text]

11. Suzuki T., Sugii M., Kakimoto T. New {gamma}-glutamyl peptides in garlic. Chem. Pharm. Bull. 1961;9:77-78

12. Synge R.L.M., Wood J. C. (+)-(S-methyl-L-cysteine S-oxide) in cabbage. Biochem. J. 1956;64:252-259[Medline]

13. Takada N., Kitano M., Chen T., Yano Y., Otani S., Fukushima S. Enhancing effects of organosulfur compounds from garlic and onions on hepatocarcinogenesis in rats: association with increased cell proliferation and elevated ornithine decarboxylase. Jpn. J. Cancer Res. 1994a;85:1067-1072[Medline]

14. Takada N., Matsuda T., Otoshi T., Yano Y., Otani S., Hasegawa T., Nakae D., Konishi Y., Fukushima S. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res 1994b;54:2895-2899[Abstract/Free Full Text]

15. Takada N., Yano Y., Wanibuchi H., Otani S., Fukushima S. S-Methylcysteine and cysteine are inhibitors of induction of glutathione S-transferase placental form-positive foci during initiation and promotion phases of rat hepatocarcinogenesis. Jpn. J. Cancer Res. 1997;88:435-442[Medline]

16. Takahashi S., Hakoi K., Yada H., Hirose M., Ito N., Fukushima S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis 1992a;13:1513-1518[Abstract/Free Full Text]

17. Takahashi S., Hasegawa R., Masui T., Mizoguchi M., Fukushima S., Ito N. Establishment of multi-organ carcinogenesis bioassay using rats treated with combination of five different carcinogens. J. Toxicol. Pathol. 1992b;5:151-156

18. Thompson J. F., Morris C. J., Zacharius R. M. Isolation of (-)S-methyl-L-cysteine from beans (Phaseolus vulgaris). Nature (Lond.) 1956;178:593

19. Tsuda H., Uehara N., Iwahori Y., Asamoto M., Iigo M., Nagao M., Matsumoto K., Ito M., Hirono I. Chemopreventive effects of ß-carotene, {alpha}-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methyllimidazo[4,5-f]quinoline in the rat. Jpn. J. Cancer Res. 1994;85:1214-1219[Medline]

20. Tudek B., Bird R. P., Bruce W. R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with food. Cancer Res 1989;49:1236-1240[Abstract/Free Full Text]

21. Wargovich M. J. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 1987;8:487-489[Abstract/Free Full Text]

22. Wargovich M. J., Woods C., Eng V.W.S., Stephens L. C., Gray K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res 1988;48:6872-6875[Abstract/Free Full Text]

23. Wattenberg L. W., Sparnins V. L., Barany G. Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res 1989;49:2689-2692[Abstract/Free Full Text]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukushima, S.
Right arrow Articles by Yamamoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukushima, S.
Right arrow Articles by Yamamoto, S.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]